Integrum’s technology using AI gives an above-elbow amputee unprecedented control of every finger in a bionic hand
Mölndal, Sweden, July 13, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the first case study of a person with above-elbow amputation obtaining unprecedented control of every finger in a bionic hand has been published in Science Translational Medicine. By combining Integrum’s OPRA™ Implant System and e-OPRA™ Implant System with revolutionary surgical and engineering advancements and AI algorithms, the user’s intentions were translated into the movement of the bionic fingers.The scientific paper illustrates how Integrum’s technology combined with